中文摘要：

目的探讨肿瘤转移抑制基因-1（TMSG-1，亦称LASS2）在人不同转移潜能前列腺癌细胞株中与前列腺癌组织中的表达及其临床意义。方法采用实时荧光定量聚合酶链反应（PCR）及细胞爬片免疫荧光组织化学方法，检测TMSG-1在人不同转移潜能前列腺癌细胞株低转移潜能（PC-3M-284）和高转移潜能（PC-3M—IE8）中的表达。并采用免疫组织化学方法检测TMSG-1在人前列腺增生及前列腺癌组织中的表达，同时探讨其与临床病理特征之间的关系。结果TMSG-1在PC-3M-284细胞株中的mRNA及蛋白表达（2．70±0．30、75．26±2．68）均明显高于在PC-3M—IE8细胞株中的表达（1．10±0．20、38．08±1．84），差异有统计学意义（P〈0．05）。通过免疫组织化学观察表明TMSG．1在前列腺增生及前列腺癌组织中均有表达，但在前列腺增生中的阳性表达率（32／40）明显高于在前列腺癌中的阳性表达率（21／60），两者差异有统计学意义（P〈0．05）。并且TMSG-1在前列腺癌组织中的表达与年龄、Gleason分级、淋巴结转移及TNM分期密切相关（P〈0．05），而与肿瘤的大小无明显相关。结论TMSG-1在低转移潜能前列腺癌细胞株中的mPtNA及蛋白表达明显高于在高转移潜能前列腺癌细胞株中的表达，证明它是一种肿瘤转移抑制基因。TMSG-1在人前列腺增生与前列腺癌组织中的表达之间差异有统计学意义，并且TMSG-1在前列腺癌中的表达与年龄、Gleason分级、淋巴结转移及TNM分期密切相关。

英文摘要：

Objective To investigate the expression of tumor metastasis suppressor gene 1 （TMSG-1 as well LASS2） in different prostate cancer cell lines and prostate cancer tissues and its clinical significance. Methods Sixty patients with prostate cancer had undergone surgery between 2008 and 2010. Forty patients with prostatic hyperplasia were chosen. Immunofluorescence histocbemistry was used to study the distribution of TMSG-1 in cells, immunohistochemistry was used to observe the difference in TMSG-1 expression between prostatic hyperplasia and prostate cancer tissues, and the relationship between the TMSG-lexpression and clinicopathological features in prostate cancer tissues was analyzed. Results The level of TMSG-1 mRNA in PC-3 M-2B4 cell line with low metastatic potentiality （2.70 ＋ 0. 30） was higher than in PC-3M-IE8 cell line （1.10 ＋0. 20）. Immunofluorescence histochemistry revealed that most of the collected prostate cancers and prostatic hyperplasia tissues expressed TMSG-1 in cytoplasma, and nuclei were stained in a few of prostate cancer tissues. The average fluorescence intensity of TMSG-1 in PC-3M- 2B4 cells （75.26 ＋2. 68） was obviously higher than in PC-3M-IE8 cells （38. 08 ＋ 1. 84）. There was ob- viously different expression of TMSG-1 between prostate cancers （21/60） and prostatic hyperplasia （32/40） （ P 〈 0. 05 ）. The TMSG-1 levels in prostate cancer tissue were significantly correlated with ages, Gleason grade, lymph node metastasis and tumor, nodes, metastasis （TNM） staging （ P 〈 0.05 ）, but not with the size of tumor. Conclusion The expression level of TMSG-1 mRNA and protein in prostate cancer cell lines with low metastatic potentials significantly higher than in prostate carcinoma cell lines with high me- tastatic potentials, which proves that TMSG-1 is a tumor metastasis suppressor gene. From the difference in the TMSG-1 expression between human prostatic hyperplasia and prostate cancer tissues and the correlation with age, Gleason grade, lymph nod